KULJIT SINGH: Open Payments
NPI 1548236854 · WEST NYACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,965 in 69 payments from 13 companies in 2025. Trend: 2023 $1,171 · 2024 $1,777 · 2025 $1,965
Food & beverage: $1,965
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 19 | $623 |
| E.R. Squibb & Sons, L.L.C. | 13 | $272 |
| ABBVIE INC. | 13 | $212 |
| Neurocrine BioSciences, Inc. | 4 | $197 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $191 |
| Otsuka America Pharmaceutical, Inc. | 3 | $155 |
| Alkermes, Inc. | 4 | $98 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Supernus Pharmaceuticals, Inc. | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
Products named: Auvelity, COBENFY, VRAYLAR, INGREZZA, CAPLYTA, ABILIFY MAINTENA, FANAPT, ARISTADA.
Industry payments across NY — which companies pay providers there.
